Browsing by Author Thiele, J.

Jump to a point in the index:
Showing results 1 to 19 of 19
PreviewIssue DateCreated DateTitle
Bone marrow histopathology in chronic myelogenous leukemia CML evaluation of distinctive features with clinical impact.pdf.jpg1999-Bone marrow histopathology in chronic myelogenous leukemia ,CML, evaluation of distinctive features with clinical impact
lmmunoreactivity of ThomsenFriedenreich TF antigen in human neoplasms. The importance of carrierspecific glycotope expression on MUC.pdf.jpg1999-lmmunoreactivity of Thomsen-Friedenreich ,TF, antigen in human neoplasms. The importance of carrier-specific glycotope expression on MUC
Bone marrow engraftment histopathology of hematopoietic reconstitution following allogeneic transplantation in CML patients.pdf.jpg2001-Bone marrow engraftment: histopathology of hematopoietic reconstitution following allogeneic transplantation in CML patients
Immunoreactivity of Lewis blood group and mucin peptide core antigens Correlations with grade of dysplasia.pdf.jpg2002-Immunoreactivity of Lewis blood group and mucin peptide core antigens: Correlations with grade of dysplasia and malignant transformation in the colorectal adenoma-carcinoma sequence
CD34 stem cells in chronic myeloproliferative disorders.pdf.jpg2002-CD34+ stem cells in chronic myeloproliferative disorders
Dynamics of lineagerestricted.pdf.jpg2003-Dynamics of lineage-restricted mixed chimerism following sex-mismatched allogeneic bone marrow transplantation
Diagnostic differentiation of essential.pdf.jpg2003-Diagnostic differentiation of essential thrombocythaemia from thrombocythaemias associated with chronic idiopathic myelofibrosis by discriminate analysis of bone marrow features - a clinicopathological study on 272 patients
Regeneration of heart muscle tissue.pdf.jpg2004-Regeneration of heart muscle tissue: quantification of chimeric cardiomyocytes and endothelial cells following transplantation
Therapyrelated changes of the bone marrow in chronic....pdf.jpg2004-Therapy-related changes of the bone marrow in chronic idiopathic myelofibrosis
Bone marrow angiogenesis methods.pdf.jpg2004-Bone marrow angiogenesis: methods of quantification and changes evolving in chronic myeloproliferative disorders
Effects of the tyrosine kinase inhibitor.pdf.jpg2004-Effects of the tyrosine kinase inhibitor Imatinib mesylate (STI571) on bone marrow features in patients with chronic myelogenous leukemia
Anagrelide does not exert a myelodysplastic effect on.pdf.jpg2005-Anagrelide does not exert a myelodysplastic effect on megakaryopoiesis: a comparative immunohistochemical and morphometric study with hydroxyurea
Dynamics of bone marrow changes in.pdf.jpg2005-Dynamics of bone marrow changes in patients with chronic idiopathic myelofibrosis following allogeneic stem cell transplantation
Diagnostic impact of bone marrow.pdf.jpg2005-Diagnostic impact of bone marrow histopathology in polycythemia vera (PV)
Standardization of bone marrow.pdf.jpg2005-Standardization of bone marrow features - does it work in hematopathology for histological discrimination of different disease patterns?
Myelofibrosis in chronic myeloproliferative disorders  dynamics and clinical impact.pdf.jpg2006-Myelofibrosis in chronic myeloproliferative disorders - dynamics and clinical impact
Lewis y antigen CD174 and apoptosis in gastric and colorectal carcinomas Correlations with clinical and prognostic parameters.pdf.jpg2006-Lewis y antigen (CD174) and apoptosis in gastric and colorectal carcinomas, Correlations with clinical and prognostic parameters
MUC1 EMA expressing plasma cells in bone marrow infiltrated by plasma cell myeloma.pdf.jpg2007-MUC1 (EMA) expressing plasma cells in bone marrow infiltrated by plasma cell myeloma
Dualism of mixed chimerism between hematopoiesis and stroma in chronic idiopathic myelofibrosis after allogeneic stem cell transplantation.pdf.jpg2007-Dualism of mixed chimerism between hematopoiesis and stroma in chronic idiopathic myelofibrosis after allogeneic stem cell transplantation